|
Nanoscale Peptide Separation System, GE Healthcare
04-22-2006
SHARING OPTIONS:
GE Healthcare recently launched a nanoscale 1D-LC peptide
separation system that combines excellent reproducibility with accurate
performance. The Ettan nanoLC is a fully bio-inert, robust, nanoscale
peptide separation system that, according to GE Healthcare, delivers
highly reproducible performance and is ideal for 1D-LC proteomics
applications upstream from electrospray ionization MS or MALDI MS/MS
applications. The nanoLC extends the range of applications of GE
Healthcare's family of Ettan chromatography systems. The nanoLC
is designed for those with limited funding requiring a dedicated 1D-LC
system who don't want to compromise on the high sensitivity enabled by
the LC platform. The Ettan nanoLC performs high-pressure gradient
formation with high reproducibility and online, real-time gradient
monitoring, while maintaining a continuous flow to the ion source or
MALDI spotter throughout a run. The instrument's low dead volumes
ensure minimum peak broadening and consistent peak concentrations for
maximum sensitivity and resolution. The bio-inert system offers
advantages for peptide separation of labile phosphopeptides upstream
from electrospray ionization MS. Integrated system components include a
flow splitter that ensures gradient elution at flow rates as low
as 200 nL/min, UV and conductivity monitors, the P-905 pump, a pressure
sensor, and biocompatible flow path and pump heads. The Peltier-cooled
Autosampler A-905 allows injection of as little as 100 nL of sample
from vials or microtiter plates.
GE Healthcare
800.526.3593
Back |
Home |
FAQs |
Search |
Submit News Release |
Site Map |
About Us |
Advertising |
Resources |
Contact Us |
Terms & Conditions |
Privacy Policy
|